Daily Activity and Gait Analysis After Viscosupplement Injection Among Hip Osteoarthritis Patients

NCT02086474 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2018-08-10

No results posted yet for this study

Summary

The objective of this study is to assess the changes in daily physical activity and gait pattern, following a viscosupplement injection among a population who is suffering from hip osteoarthritis. A kinetic and kinematic gait analysis, an Actigraph activity monitor, a functional Timed-Stair-Test and two questionnaires (Medical Outcome Study Short-Form36 (MOS-SF36), Hip disability and Osteoarthritis Outcome Score (HOOS)) about how the pathology affects the quality of life, will be use.

Conditions

  • Hip Osteoarthritis

Interventions

DRUG

Hyaluronan

Intra-articular injection

DRUG

Bupivacaine

Extra-capsular injection

Sponsors & Collaborators

  • Laval University

    lead OTHER

Principal Investigators

  • Antoine Cantin-Warren, B.Sc. · Laval University

  • Étienne L. Belzile, MD · Laval University

  • Philippe Corbeil, Ph.D. · Laval University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2017-08-31
Completion
2017-08-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02086474 on ClinicalTrials.gov